OpenCell works with Government of Jersey to provide on-island testing

COVID-19

Home » Health and medicine » COVID-19

Amyris and The Infectious Disease Research Institute Enter into Exclusive License for Novel RNA Vaccine Platform, Beginning with COVID-19 Vaccine

EMERYVILLE, Calif., Oct. 22, 2020 /PRNewswire/ — Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of...

Chai Launches First Saliva-Based COVID-19 Surveillance Test Kit To Help Schools And Businesses Reopen Safely

Sherlock Biosciences Launches The 221b Foundation to Address the COVID-19 Pandemic and Equity in STEM

September 15, 2020 Nonprofit Will Enable Access to Proprietary SHERLOCK™ CRISPR-based Technology to Support Third-party Development of COVID-19 Diagnostic Tests Proceeds to Support Racial and Gender Diversity in STEM...

Biopharma Leaders Unite to Stand with Science

testing

How Do We Safely Reopen Schools And Work? Cheap, Fast Testing, Enabled By A $5 Million XPRIZE

Twist Bioscience Announces Potent SARS-CoV-2 Neutralizing Data from COVID-19 Therapeutic Antibody Program

Sherlock Biosciences Announces Clinical Data from Dartmouth-Hitchcock Health’s Pilot Study of Sherlock™ CRISPR SARS-CoV-2 Kit

GenScript Biotech Corporation signs exclusive agreement with PH biotech firm to distribute faster, more accurate and more affordable immunity tests for COVID-19

Ingenza meets a key milestone in the deployment of novel cost-effective COVID-19 vaccine technology

Sherlock Biosciences Announces Research Collaboration with Dartmouth-Hitchcock Health to Launch Study of CRISPR-based Test for SARS-CoV-2

AbCellera Provides COVID-19 Program Update with the Start of Phase 3 Clinical Trials and the Expansion of its COVID-19 Antibody Database

antibody test

A New Test May Show Whether Your Immune System Can Neutralize The Coronavirus

Twist Bioscience Launches Two SARS-CoV-2 Antibody Panels to Expedite Research for COVID-19

Amyris and The Infectious Disease Research Institute Partner to Advance Novel RNA Vaccine Platform Beginning With COVID-19 Application

GenScript Announces Publication of Clinical Data On New Method for Detecting COVID-19 Neutralizing Antibodies In Nature Biotechnology